Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome

In clinical practice, few prostate cancer (PCa) patients are associated with metabolic syndrome (MetS), while few others acquire MetS during treatment. Whether the treatment of PCa increases the occurrence of MetS remains to be confirmed. This study reviewed the changes in MetS patients before and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zongping, Deng, Jichun, Yan, Yong, Li, Min, Chen, Chanjuan, Chen, Chao, Zhao, Sicong, Song, Tao, Liu, Tong, Wen, Xin, Yao, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061238/
https://www.ncbi.nlm.nih.gov/pubmed/29948970
http://dx.doi.org/10.1007/s12672-018-0335-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061238/
https://www.ncbi.nlm.nih.gov/pubmed/29948970
http://dx.doi.org/10.1007/s12672-018-0335-8

Ejemplares similares